Coincidence but maybe also fortuitousFDA Oncology's Richard Pazdur, MD, recently traveled to Poland and met with medical product regulators from to compare regulatory systems and oncology drug development.QuoteURPL@URPLWMiPB·Apr 19Today we hosted a representative of our sister office from @US_FDA, Dr. Richard Pazdur, Director of the Oncology Center of Excellence. The meeting was an opportunity to identify and compare similarities within our administrations and to talk about the EU regulatory system.
Ann: Positive initial data in phase 2 Soft Tissue Sarcoma trial, page-17
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $534.9M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3373 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 2712 | 1 |
View Market Depth
| Last trade - 16.16pm 03/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
Day chart unavailable